These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 22133718)

  • 1. Testing the right target and right drug at the right stage.
    Sperling RA; Jack CR; Aisen PS
    Sci Transl Med; 2011 Nov; 3(111):111cm33. PubMed ID: 22133718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Discoveries on Multi-Target Approach to Manage Alzheimer's Disease.
    Batool A; Kamal MA; Rizvi SMD; Rashid S
    Curr Drug Metab; 2018; 19(8):704-713. PubMed ID: 29512457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug development for overcoming dementia in Japan].
    Nakamura H
    Rinsho Shinkeigaku; 2014; 54(12):1181-3. PubMed ID: 25672739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Defining and disease-modifying therapy for the preclinical stages of Alzheimer's disease].
    Sakurai H; Hanyu H
    Nihon Rinsho; 2016 Mar; 74(3):438-41. PubMed ID: 27025083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-dementia Alzheimer's trials: overview.
    Aisen PS
    J Nutr Health Aging; 2010 Apr; 14(4):294. PubMed ID: 20305998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toward Preclinical Trials for Alzheimer's Disease].
    Miyagawa T; Iwatsubo T
    Brain Nerve; 2017 Jul; 69(7):711-722. PubMed ID: 28739984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Alzheimer's disease drug development.
    Rafii MS; Aisen PS
    BMC Med; 2015 Mar; 13():62. PubMed ID: 25857341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking Alzheimer's disease therapy: are mitochondria the key?
    Ankarcrona M; Mangialasche F; Winblad B
    J Alzheimers Dis; 2010; 20 Suppl 2():S579-90. PubMed ID: 20463405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint.
    Mani RB
    Stat Med; 2004 Jan; 23(2):305-14. PubMed ID: 14716731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials.
    Olsson B; Schott JM; Blennow K; Zetterberg H
    Expert Rev Neurother; 2017 Aug; 17(8):767-775. PubMed ID: 28604243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic frontiers in Alzheimer's disease.
    Miller SW; Mahoney JM; Jann MW
    Pharmacotherapy; 1992; 12(3):217-31. PubMed ID: 1608856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.
    Salomone S; Caraci F; Leggio GM; Fedotova J; Drago F
    Br J Clin Pharmacol; 2012 Apr; 73(4):504-17. PubMed ID: 22035455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
    Mullane K; Williams M
    Biochem Pharmacol; 2018 Dec; 158():376-401. PubMed ID: 30273552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease: from pathogenesis to disease-modifying approaches.
    Galimberti D; Scarpini E
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):163-74. PubMed ID: 21222635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Drug Therapy for Alzheimer's Disease.
    Zhu CC; Fu SY; Chen YX; Li L; Mao RL; Wang JZ; Liu R; Liu Y; Wang XC
    Curr Med Sci; 2020 Dec; 40(6):999-1008. PubMed ID: 33428127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.
    Bachurin SO; Bovina EV; Ustyugov AA
    Med Res Rev; 2017 Sep; 37(5):1186-1225. PubMed ID: 28084618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatments in Alzheimer's disease.
    Briggs R; Kennelly SP; O'Neill D
    Clin Med (Lond); 2016 Jun; 16(3):247-53. PubMed ID: 27251914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the therapy of Alzheimer's disease: targeting amyloid beta and tau and perspectives for the future.
    Hampel H; Schneider LS; Giacobini E; Kivipelto M; Sindi S; Dubois B; Broich K; Nisticò R; Aisen PS; Lista S
    Expert Rev Neurother; 2015 Jan; 15(1):83-105. PubMed ID: 25537424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.